Clinical Trial Update: A Pilot Pharmacokinetic Phase I Evaluation of BI-RG-587 in HIV-Infected Children [NA]

View source ↗

Summary

This clinical trial update reports pharmacokinetic results from a pilot Phase I evaluation of BI-RG-587 in HIV-infected children, conducted by NIAID. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• BI-RG-587

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | NA | Status: COMPLETED